Here is what I’m reading as we kick off the workweek:
- This Startup Is Developing Finger-Prick Blood Tests, But Don’t Call It Theranos 2 (Forbes)
- The Week Ahead In Biotech: Conferences, Clinical Trial Results, IPOs and More (Benzinga).
- Azar says ‘change is coming’ for 340B (BioPharma Dive)
- This smartwatch with an Uber-like twist is aiming to transform emergency cardiac care (Med City News)